Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions

NCT: NCT07515703 · COMPLETED

NCT IDNCT07515703
StatusCOMPLETED
Start Date2019-03-01
Completion2026-03-01

Brief Summary

The optimal management of severely calcified coronary artery disease remains challenging, particularly in the context of drug-coated balloon (DCB) angioplasty. This study aimed to evaluate the feasibility, safety, and mid-term clinical outcomes of a DCB-only strategy following coronary modification systems (CMS) in patients with heavily calcified de novo coronary atherosclerotic disease.

Frequently Asked Questions

What is Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions?

Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions is a clinical trial registered under NCT07515703. Current status: COMPLETED.

What is the status of NCT07515703?

The current status of NCT07515703 (Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions) is: COMPLETED.

When did Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions start?

Plaque Modification and Drug Coated Balloons for Treatment of de Novo Calcific Coronary Lesions started on 2019-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑